Craft

IDEXX Laboratories

Stock Price

$447.8

2024-10-29

Market Capitalization

$36.9 B

2024-10-29

Revenue

$4.3 B

FY, 2025

IDEXX Laboratories Summary

Company Summary

Overview
IDEXX Laboratories is a company that develops, manufactures, and distributes diagnostic equipment and tests for veterinary use, water quality assessment, and livestock health. Its offerings include in-clinic analyzers for chemistry, hematology, immunoassay, urinalysis, rapid assay test kits, reference laboratory services, veterinary management software, water tests for coliforms and E. coli, and equipment. The company serves companion animal veterinarians, livestock producers, dairy operations, and water utilities.
Type
Public
Status
Active
Founded
1983
HQ
Westbrook, ME, US | view all locations
Website
http://www.idexx.com
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key People

  • Jay Mazelsky

    Jay Mazelsky, President, Chief Executive Officer & Director

  • Martin Smith

    Martin Smith, Executive Vice President Chief Technology Officer

    • Sharon E. Underberg

      Sharon E. Underberg, Executive Vice President General Counsel and Corporate Secretary

    • Michael Lane

      Michael Lane, Executive Vice President, General Manager, Reference Laboratories and Information Technology

      Operating MetricsView all

      Facilities Owned

      2

      FY, 2021

      Installed Base (Catalyst)

      56.5K
      13.9%

      FY, 2021

      Installed Base (Premium Hematology)

      38.2K
      10.4%

      FY, 2021

      LocationsView all

      45 locations detected

      • Westbrook, ME HQ

        United States

        Idexx Dr

      • Clackamas, OR

        United States

        9200 SE Sunnybrook Blvd #460

      • Eau Claire, WI

        United States

        2536 Alpine Rd

      • Memphis, TN

        United States

        6100 E Shelby Dr

      • Roswell, GA

        United States

        200 Hembree Park Dr Suite J

      • East Brisbane, QLD

        Australia

        3 Overend St

      and 39 others

      IDEXX Laboratories Financials

      Summary Financials

      Revenue (Q1, 2026)
      $1.1B
      Gross profit (Q1, 2026)
      $722.7M
      Net income (Q1, 2026)
      $278.4M
      Cash (Q1, 2026)
      $200.5M
      EBIT (Q1, 2026)
      $362.6M
      Enterprise value
      $37.7B

      Footer menu